Relacatib Uses, Dosage, Side Effects and more
| Trade Name | Relacatib |
| Generic | Relacatib |
| Relacatib Other Names | Relacatib |
| Type | |
| Formula | C27H32N4O6S |
| Weight | Average: 540.64 Monoisotopic: 540.20425594 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in osteoporosis and bone metastases.
How Relacatib works
Relacatib is a small-molecule drug that inhibits the activity of cathepsin K, an enzyme that appears to be implicated in osteoporosis, osteoarthritis and certain other disorders causing bone degradation.
